PURPOSE: The aim of this retrospective study was to review the clinical fea
tures, and surgical and medical management of patients with familial adenom
atous polyposis-associated desmoid tumors. METHODS: From 1980 to 1997, 97 o
f 780 patients with familial adenomatous polyposis developed desmoid diseas
e. Clinical and demographic data; operative notes; and histologic, radiolog
ic, and follow-up reports were retrieved from patients' medical records. Ri
sk factors for desmoid disease, such as prior surgery, age at desmoid tumor
diagnosis, pregnancy, and family history were sought. The outcome after no
ncytotoxic and cytotoxic therapy was evaluated with respect to improvement
of symptoms. RESULTS: There were 38 males with a mean age of 32.1 years and
59 females with a mean age of 29.1 years. A family history of desmoid tumo
rs was found in 41 patients (42 percent), and a history of pregnancy was do
cumented in 33 females (56 percent). The most common clinical presentation
was small-bowel obstruction (58 percent). One-half of the desmoids were loc
ated in the mesentery, and 32 percent were located in the mesentery and the
abdominal wall. Desmoids developed after colectomy in 77 cases (80 percent
), after a mean time of 4.6 years. Partial resection of desmoid tumor was p
erformed in 46 patients (47 percent), resection of extra-abdominal. desmoid
tumors was performed in 17 cases (17 percent), and biopsy only was perform
ed in 34 patients (35 percent). Postoperative morbidity was 23 percent afte
r desmoid tumor resection. Eight patients (8 percent) died of their intra-a
bdominal desmoid. Mean follow-up time was 5.3 years. Sulindac, tamoxifen, o
r toremifene therapy was able to alleviate symp toms in only 4 of 31 patien
ts. Symptomatic improvement was noted after chemotherapy in six of ten pati
ents with extremely complex desmoids. CONCLUSION: Desmoid disease was found
in 12.4 percent of our patients with familial adenomatous polyposis. In vi
ew of the high rate of morbidity, indication for surgery should be limited
mainly to acute or chronic small-bowel obstruction, because resection trigg
ers a high recurrence rate. Noncytotoxic therapy was not effective for prog
ressive desmoid tumors, whereas chemotherapy was effective in aggressive ca
ses of intra-abdominal desmoid tumors.